Compare · OPCH vs REUN
OPCH vs REUN
Side-by-side comparison of Option Care Health Inc. (OPCH) and Reunion Neuroscience Inc. (REUN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OPCH and REUN operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- OPCH carries a market cap of $4.46B.
- OPCH has hit the wire 4 times in the past 4 weeks while REUN has been quiet.
- OPCH has more recent analyst coverage (13 ratings vs 0 for REUN).
- Company
- Option Care Health Inc.
- Reunion Neuroscience Inc.
- Price
- $28.41-0.49%
- $1.13+1.80%
- Market cap
- $4.46B
- -
- 1M return
- -0.28%
- -
- 1Y return
- -13.83%
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 4
- 0
- Recent ratings
- 13
- 0
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest OPCH
- Chief Medical Officer Adewunmi Femi covered exercise/tax liability with 1,396 shares, decreasing direct ownership by 5% to 25,314 units (SEC Form 4)
- SEC Form DEFA14A filed by Option Care Health Inc.
- SEC Form DEF 14A filed by Option Care Health Inc.
- Option Care Health to Announce First Quarter 2026 Financial Results and Host Conference Call
- Option Care Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Amendment: SEC Form SCHEDULE 13G/A filed by Option Care Health Inc.
- Chief Human Resources Officer Bavaro Michael sold $198,000 worth of shares (6,000 units at $33.00), decreasing direct ownership by 15% to 33,249 units (SEC Form 4)
- Director Pate R Carter sold $970,620 worth of shares (30,287 units at $32.05), decreasing direct ownership by 72% to 11,623 units (SEC Form 4)
- Chief Operating Officer Whitworth Luke covered exercise/tax liability with 4,605 shares, decreasing direct ownership by 3% to 169,589 units (SEC Form 4)
- Chief Growth Officer Grashoff Christopher L. covered exercise/tax liability with 1,980 shares, decreasing direct ownership by 4% to 44,092 units (SEC Form 4)
Latest REUN
- SEC Form 15-12G filed by Reunion Neuroscience Inc.
- Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
- Reunion Neuroscience Completes Take-Private Setup: Delisting & Consideration Details
- SEC Form 6-K filed by Reunion Neuroscience Inc.
- SEC Form SC 13D/A filed by Reunion Neuroscience Inc. (Amendment)
- SEC Form F-10POS filed by Reunion Neuroscience Inc.
- SEC Form S-8 POS filed by Reunion Neuroscience Inc.
- SEC Form S-8 POS filed by Reunion Neuroscience Inc.
- SEC Form 25-NSE filed by Reunion Neuroscience Inc.
- Reunion Neuroscience Inc. and MPM BioImpact Announce Completion of Plan of Arrangement